Suramin decreases circulating levels of insulin-like growth factor-I.
Sartor
O
O
Clinical Pharmacology Branch, National Cancer Institute, Bethesda, MD.
Cooper
M R
MR
Khleif
S N
SN
Myers
C E
CE
D000704:Analysis of Variance; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000187:drug effects*; D008297:Male; D011446:Prospective Studies; D011471:Prostatic Neoplasms / Q000097:blood; D013498:Suramin / Q000494:pharmacology*
D013498:Suramin; D007334:Insulin-Like Growth Factor I